IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Inmed Pharmaceuticals Inc (INM)

CUSIP: 457637700 | NYSE | 32 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AAdar1 Capital Management, LLC943,66817.2%New 5%+ stakeSep 30, 2026No 13F filer matched
13GIkarian Capital, LLC137,6344.2%Newly reportedJun 30, 2026

Institutional Holders — Q3 2026

Crestwood Advisors Group, LLC14,900
0.0% of portfolio›$20.3K
Private Wealth Management Group, LLC5,000
0.0% of portfolio›$6.8K
SBI Securities Co., Ltd.300
0.0% of portfolio›$408
StyleTurnoverLocationFiled
Crestwood Advisors Group, LLC
14,900$20.3K0.0%GrowthLowBoston, MA2026-10-27
Private Wealth Management Group, LLC
5,000$6.8K0.0%ETFLowPrinceton, NJ2026-10-19
SBI Securities Co., Ltd.
300$4080.0%Agg GrowthLowTokyo, Mexico2026-10-22
No 13F filer matched
13DVivo Opportunity Fund Holdings, L.P.
with Vivo Opportunity Cayman Fund, L.P., Vivo Opportunity Cayman, LLC
718,44421.7%New 5%+ stakeMay 19, 2026No 13F filer matched
13G/AAdar1 Capital Management, LLC943,668
17.2% of class · Sep 30, 2026New 5%+ stake
No 13F filer matched
13GIkarian Capital, LLC137,634
4.2% of class · Jun 30, 2026Newly reported
No 13F filer matched
13DVivo Opportunity Fund Holdings, L.P.718,444
21.7% of class · May 19, 2026New 5%+ stake
with Vivo Opportunity Cayman Fund, L.P., Vivo Opportunity Cayman, LLC
No 13F filer matched